205 related articles for article (PubMed ID: 24886852)
41. Past-year prevalence of prescription opioid misuse among those 11 to 30years of age in the United States: A systematic review and meta-analysis.
Jordan AE; Blackburn NA; Des Jarlais DC; Hagan H
J Subst Abuse Treat; 2017 Jun; 77():31-37. PubMed ID: 28476268
[TBL] [Abstract][Full Text] [Related]
42. Chronic pain management among people who use drugs: A health policy challenge in the context of the opioid crisis.
Dassieu L; Kaboré JL; Choinière M; Arruda N; Roy É
Int J Drug Policy; 2019 Sep; 71():150-156. PubMed ID: 30975594
[TBL] [Abstract][Full Text] [Related]
43. The epidemiology of prescription fentanyl misuse in the United States.
Schepis TS; McCabe VV; Boyd CJ; McCabe SE
Addict Behav; 2019 Sep; 96():89-93. PubMed ID: 31063940
[TBL] [Abstract][Full Text] [Related]
44. Assessing the prevalence of non-medical prescription opioid use in the Canadian general adult population: evidence of large variation depending on survey questions used.
Shield KD; Ialomiteanu A; Fischer B; Rehm J
BMC Psychiatry; 2013 Jan; 13():6. PubMed ID: 23286378
[TBL] [Abstract][Full Text] [Related]
45. Prevalence and correlates of nonmedical prescription opioid use among a cohort of sex workers in Vancouver, Canada.
Argento E; Chettiar J; Nguyen P; Montaner J; Shannon K
Int J Drug Policy; 2015 Jan; 26(1):59-66. PubMed ID: 25148695
[TBL] [Abstract][Full Text] [Related]
46. Prescription opioid misuse in the United States and the United Kingdom: cautionary lessons.
Weisberg DF; Becker WC; Fiellin DA; Stannard C
Int J Drug Policy; 2014 Nov; 25(6):1124-30. PubMed ID: 25190034
[TBL] [Abstract][Full Text] [Related]
47. Heroin use onset among nonmedical prescription opioid users in the club scene.
Surratt HL; Kurtz SP; Buttram M; Levi-Minzi MA; Pagano ME; Cicero TJ
Drug Alcohol Depend; 2017 Oct; 179():131-138. PubMed ID: 28772173
[TBL] [Abstract][Full Text] [Related]
48. The 'fentanyl epidemic' in Canada - Some cautionary observations focusing on opioid-related mortality.
Fischer B; Vojtila L; Rehm J
Prev Med; 2018 Feb; 107():109-113. PubMed ID: 29126920
[TBL] [Abstract][Full Text] [Related]
49. Trends and sex differences in prescription opioid deaths in British Columbia, Canada.
Gladstone EJ; Smolina K; Morgan SG
Inj Prev; 2016 Aug; 22(4):288-90. PubMed ID: 26195562
[TBL] [Abstract][Full Text] [Related]
50. Cognitive and socio-cognitive functioning of chronic non-medical prescription opioid users.
Kroll SL; Nikolic E; Bieri F; Soyka M; Baumgartner MR; Quednow BB
Psychopharmacology (Berl); 2018 Dec; 235(12):3451-3464. PubMed ID: 30310961
[TBL] [Abstract][Full Text] [Related]
51. A decade of extreme oscillations in opioid control and availability: implications for public health in a Canadian setting.
Fischer B; Wood E
J Public Health Policy; 2020 Jun; 41(2):214-220. PubMed ID: 32054979
[TBL] [Abstract][Full Text] [Related]
52. Between a rock and a hard place: Prescription opioid restrictions in the time of fentanyl and other street drug adulterants.
Cheng T; DeBeck K
Can J Public Health; 2017 Sep; 108(3):e325-e327. PubMed ID: 28910257
[TBL] [Abstract][Full Text] [Related]
53. A perioperative approach to the opioid crisis.
Bai JW; Bao J; Bhatia A; Chan VWS
CMAJ; 2018 Oct; 190(39):E1151-E1152. PubMed ID: 30274991
[No Abstract] [Full Text] [Related]
54. Prevalence of pain among nonmedical prescription opioid users in substance use treatment populations: systematic review and meta-analyses.
Lusted A; Roerecke M; Goldner E; Rehm J; Fischer B
Pain Physician; 2013; 16(6):E671-84. PubMed ID: 24284850
[TBL] [Abstract][Full Text] [Related]
55. 'Resurgent', 'twin' or 'silent' epidemic? A select data overview and observations on increasing psycho-stimulant use and harms in North America.
Fischer B; O'Keefe-Markman C; Lee AM; Daldegan-Bueno D
Subst Abuse Treat Prev Policy; 2021 Feb; 16(1):17. PubMed ID: 33588896
[TBL] [Abstract][Full Text] [Related]
56. The Opioid Epidemic: Challenge to Military Medicine and National Security.
Dembek ZF; Chekol T; Wu A
Mil Med; 2020 Jun; 185(5-6):e662-e667. PubMed ID: 32077961
[TBL] [Abstract][Full Text] [Related]
57. Geographic Variations in Prescription Opioid Dispensations and Deaths Among Women and Men in British Columbia, Canada.
Gladstone EJ; Smolina K; Weymann D; Rutherford K; Morgan SG
Med Care; 2015 Nov; 53(11):954-9. PubMed ID: 26465123
[TBL] [Abstract][Full Text] [Related]
58. Facing the challenge of pain management and opioid misuse, abuse and opioid-related fatalities.
Cheatle MD
Expert Rev Clin Pharmacol; 2016 Jun; 9(6):751-4. PubMed ID: 26933873
[No Abstract] [Full Text] [Related]
59. Sensitivity and specificity of administrative mortality data for identifying prescription opioid-related deaths.
Gladstone E; Smolina K; Morgan SG; Fernandes KA; Martins D; Gomes T
CMAJ; 2016 Mar; 188(4):E67-E72. PubMed ID: 26622006
[TBL] [Abstract][Full Text] [Related]
60. Three noteworthy idiosyncrasies related to Canada's opioid-death crisis, and implications for public health-oriented interventions.
Fischer B; Robinson T; Jutras-Aswad D
Drug Alcohol Rev; 2024 Feb; 43(2):562-566. PubMed ID: 38098180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
